| Targeted drug delivery systems |
Extended overview |
Reviewed in Cai and Xu (2011)
|
| Anti-inflammatory drugs |
Dexamethasone |
Reviewed in Lotti et al. (2017) and Zeglio et al. (2019) (Spataro et al., 2005; Kim and Martin, 2006; Wadhwa et al., 2006; Mercanzini et al., 2010; Luo et al., 2011; Weaver et al., 2014; Alba et al., 2015; Boehler et al., 2017; de la Oliva et al., 2018b, 2019; Kleber et al., 2019) |
|
IL-1Ra |
Gutowski et al., 2015 |
|
Ibuprofen |
de la Oliva et al., 2018b |
| x |
Clodronate liposomes |
de la Oliva et al., 2018b |
|
Diclofenac |
Reviewed in Zeglio et al. (2019) (Chen et al., 2017) |
|
RGD cell adhesion ligands on glass and PEG surfaces |
Reviewed in Zeglio et al. (2019) (Anderson et al., 1999; Lynn et al., 2011; Blakney et al., 2012) |
|
Functionalization of PEG surfaces with human self-peptides |
Reviewed in Lotti et al. (2017) (Kim et al., 2014) |
| Anti-fibrotic drugs |
Extended overview |
Reviewed in Lotti et al. (2017)
|
|
Targeted silencing of CTGF via siRNAs-, miRNAs- and nanoparticle-based silencing |
Reviewed in Leask et al. (2002); Wu et al. (2008), Miele et al. (2012); Gori et al. (2015), Salazar-Montes et al. (2015); Omar et al. (2016), Surendran et al. (2017), and Saeed et al. (2018) (Xiao et al., 2014; Yu et al., 2020) |
|
CSF1R inhibition |
Doloff et al., 2017 |
| Tissue engineering strategies for targeted drug release |
Extended overview |
Reviewed in Ratner (2002); Drury and Mooney (2003), Knop et al. (2010); Balint et al. (2014), Gori et al. (2015); Lam et al. (2015), Salazar-Montes et al. (2015), and Zeglio et al. (2019)
|
|
Human self-peptides |
Rodriguez et al., 2013 |
|
Conductive polymer films |
Wadhwa et al., 2006; Mario Cheong et al., 2014; Löffler et al., 2016
|
|
Electrically-responsive microfibers |
Chen et al., 2017 |
|
Milliscale dynamic soft reservoir (DSR) |
Dolan, 2019 |
|
Embedded microfluidic channels |
Metz et al., 2004; Retterer et al., 2004; Ziegler et al., 2006; Gao et al., 2013; Takehara et al., 2014; Minev et al., 2015; Elyahoodayan et al., 2020
|
|
Hydrogel coating (e.g., pHEMA, PEG-maleimide, PVA-heparin) |
Jhaveri et al., 2009; Mario Cheong et al., 2014; Gutowski et al., 2015
|
|
CNTs nanoreserviors |
Luo et al., 2011 |
|
Electronic ion pumps |
Isaksson et al., 2007; Simon et al., 2009; Jonsson et al., 2015; Uguz et al., 2017; Proctor et al., 2018
|
|
Microencapsulation |
Campioni et al., 1998 |
|
Nanoparticle-based delivery |
Reviewed in Wu et al. (2008); Cai and Xu (2011), Miele et al. (2012); Surendran et al. (2017), and Saeed et al. (2018) (Kim and Martin, 2006; Xiao et al., 2014; Hosseini-Nassab et al., 2017; Yu et al., 2020) |
|
Electrically controlled drug delivery from graphene oxide nanocomposite film of PPy |
Weaver et al., 2014 |
